Cargando…

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra

Detalles Bibliográficos
Autores principales:	Lovillo, MS Camacho, Iglesias, E, Neth, O, Santa-María, V, Gavilán, JL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194697/ http://dx.doi.org/10.1186/1546-0096-9-S1-P4

Ejemplares similares

Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

Imaging of refractory chronic recurrent multifocal osteomyelitis succesfully treated with etanercept and methotrexate
por: Quesada-Masachs, Estefania, et al.
Publicado: (2014)

Succesful oral desensitization in a teenage boy with severe cow’s milk allergy
por: Tamay, ZU, et al.
Publicado: (2013)

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

How safe it is to treat pregnant FMF patients with Anakinra?
por: Ozdogan, H, et al.
Publicado: (2015)

The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
por: Leinonen, Mika, et al.
Publicado: (2014)

IL-1 beta receptor antagonist efficacy in the treatment of idiopathic recurrent pericarditis
por: Picco, P, et al.
Publicado: (2008)

A Case of Amaurosis Succesfully Treated by Electricity
por: Smith, Richard
Publicado: (1804)

The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review
por: Baskar, Shankar, et al.
Publicado: (2016)

P1328: SUCCESFUL TREATMENT OF GRAFT FAILURE IN AUTOLOGOUS STEM CELL TRANSPLANTATION WITH CYCLOSPORINE
por: Cubillas, D., et al.
Publicado: (2022)

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
por: Gattorno, Marco, et al.
Publicado: (2011)

Simultaneous and succesive cognitive processes.
por: Das, J. P. (Jagannath Prasad)
Publicado: (1979)

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
por: Bilginer, Y, et al.
Publicado: (2008)

Early effects of Anakinra in corticosteroid naïve SOJIA patients
por: Wulffraat, NM, et al.
Publicado: (2008)

Successful kidney transplantation during anakinra treatment without complications
por: Mulders-Manders, C, et al.
Publicado: (2015)

IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012)

Building a succesful software business
por: Radin, David
Publicado: (1994)

Complete regression of hip structural damage with anakinra: a case report
por: Aguiar, Francisca, et al.
Publicado: (2014)

The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF
por: van der Hilst, J, et al.
Publicado: (2015)

Differential response to anakinra and adalimumab in a patient with DADA2 syndrome
por: Toz, B, et al.
Publicado: (2015)

Succesful treatment of diffuse sclerosing osteomyelitis of the mandible/mandibular chronic non-bacterial osteitis with intravenous pamidronate: resolution of pain and radiographic bone inflammation with improved cosmetic appearance - a case study
por: Miettunen, Paivi, et al.
Publicado: (2014)

Succesfully treated Curvularia lunata peritonitis in a peritoneal dialysis patient
por: Kalawat, U., et al.
Publicado: (2012)

Anakinra treatment in patients with systemic-onset juvenil idiopathic arthritis: “The Valencia Experience”
por: Marvillet, I, et al.
Publicado: (2011)

Anakinra treatment in patients with Familial Mediterranean Fever: a single-center experience
por: Ugurlu, S, et al.
Publicado: (2015)

Novel intracellular function of IL-1 receptor antagonist type 1 in endothelial cells
por: Gabay, C, et al.
Publicado: (2003)

7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis
por: Miettunen, PM, et al.
Publicado: (2008)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
por: Pontikaki, I, et al.
Publicado: (2008)

Anakinra (Kineret) in psoriasis and psoriatic arthritis: a single-center, open-label, pilot study
por: Gibbs, A, et al.
Publicado: (2005)

A novel mutation in NLRC4 in a large pedigree with an anakinra responsive autoinflammatory disease
por: Volker-Touw, N, et al.
Publicado: (2015)

Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined genetic cause
por: Harrison, S, et al.
Publicado: (2015)

The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
por: Hübner, Max, et al.
Publicado: (2020)

Different molecules at the surface of stimulated T cells induce IL-1α, tumor necrosis factor and IL-1 receptor antagonist in human monocytes
por: Burger, D, et al.
Publicado: (2004)

Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
por: Ricart, S, et al.
Publicado: (2011)

Intracellular IL-1 receptor antagonist (icIL-1Ra1) does not antagonize growth inhibitory effects of pre-IL-1α in SaOS-2 cells
por: Palmer, G, et al.
Publicado: (2005)

Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)
por: Quartier, P, et al.
Publicado: (2008)

Effect of IL-1 receptor antagonist on the cerebrospinal fluid nitric oxide concentrations during experimental polymicrobial sepsis in rats
por: Wahab, Fazal, et al.
Publicado: (2013)

Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes
por: Evans, Lucy P., et al.
Publicado: (2020)

Cronic non-bacterial osteomyelitis (CNO) in a cohort of pediatric patients: clinical, biological and radiological response to treatment with Anakinra
por: Pardeo, M, et al.
Publicado: (2015)

LEP succesfully concludes its first year of physics experiments
por: CERN Press Office. Geneva
Publicado: (1990)

Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret(®)) in systemic juvenile idiopathic arthritis
por: Livermore, P, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_f4vhdfh18r3pb1m9ajnavqkf74